January 22nd, 2017
•We present a biochemical and behavioral protocol to evaluate the efficacy of mitochondria-targeted water-soluble compounds for the treatment of Spinocerebellar ataxia type 1 (SCA1) and other cerebellar neurodegenerative diseases.
Verwandte Videos
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Non-invasive Assessment of Dorsiflexor Muscle Function in Mice
A Non-Invasive Method for Generating the Cyclic Loading-Induced Intra-Articular Cartilage Lesion Model of the Rat Knee
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Advancing Male Infertility Research by Unraveling Sperm Metabolism and Mitochondrial Function
Analgesic Effect of Tuina on Rat Models with Compression of the Dorsal Root Ganglion Pain
Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten